US ▾
ALALB

Albemarle (ALB) Q1 FY26 earnings call: guidance and Q&A

Earnings call· Mar 2026 (Q1 FY26)· May 7, 2026

Source: earnings call transcript

Executive summary

Albemarle Q1 FY26 — Strong Start with Raised Specialties Outlook

Albemarle delivered a strong Q1 FY26, exceeding expectations with significant growth in net sales and adjusted EBITDA, driven by higher pricing and volumes in Energy Storage and Specialties. The company raised its full-year outlook for the Specialties segment, offsetting supply chain disruptions. Management emphasized balance sheet strengthening through debt repayment and continued focus on operational excellence and cost improvements, while navigating geopolitical uncertainties and maintaining a conservative financial posture.

Highlights

5

  • Net sales increased 33% year-over-year to $1.4 billion.

  • Adjusted EBITDA more than doubled to $664 million, reflecting higher pricing and volume.

  • Specialties net sales outlook raised to $1.3 billion to $1.5 billion for FY26.

  • Specialties adjusted EBITDA outlook raised to $225 million to $275 million for FY26.

  • Repaid $1.3 billion of debt, reducing annual interest expense by approximately $60 million.

Concerns

4

  • Estimated full-year cost impact of $70 million to $90 million from supply chain disruptions related to the Middle East.

  • Energy Storage EBITDA margin expected to decrease sequentially in Q2 due to spodumene inventory timing and higher supply chain costs.

  • Uncertainty in the Specialties outlook for the second half of the year due to geopolitical tensions and bromine price easing in China.

  • Greenbushes JV partner publicly raised concerns about safety, grade recoveries, and production stability, contrasting with management's view.

Guidance & targets

CategoryTargetConfidence
Specialties Net Sales
$1.3 billion to $1.5 billion
medium materiality
High
Specialties Adjusted EBITDA
$225 million to $275 million
medium materiality
High
Specialties EBITDA Margin
high teens
medium materiality
Medium
Total Company Outlook (Net Sales, Adjusted EBITDA, Diluted EPS)
maintained across all 3 price scenarios
high materiality
High
Cost and Productivity Improvements
$100 million to $150 million
medium materiality
High
Capital Expenditures
$550 million to $600 million
high materiality
High
Operating Cash Flow Conversion
60% to 70%
medium materiality
Medium
Energy Storage Volume Growth CAGR
15%
high materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
Energy Storage
Driven by higher pricing and volumes. The gap between realized price and market price is due to a 1-quarter pricing lag in long-term contracts and spodumene sales dilution. EBITDA margin expected to decrease sequentially in Q2 due to timing of spodumene inventory consumption and higher supply chain costs.
Sales volumes: 53,000 tons LCEAverage realized price: $17 per kilogramEBITDA growth YoY: 196%
$1.1 billion70%—Adjusted EBITDA nearly tripled
Specialties
Primarily due to higher pricing, favorable product mix, and cost/productivity improvements. Q2 net sales and EBITDA expected to increase sequentially due to higher bromine pricing. Operations at Jordan Bromine Company JV fully recovered.
Volumes up YoY: 7%EBITDA growth YoY: 30%
$300 million12%—Adjusted EBITDA increased 30%

Deals & partnerships

Eurecat Sale of joint venture

Successful sale of Eurecat joint venture.

Ketjen Sale of controlling stake

Successful sale of controlling stake in Ketjen.

Capital programs

Greenbushes CGP3 Investment operational and ramping
Start: end of 2025

The CGP3 investment there is operational and ramping as planned, with full capacity expected by year-end.

Salar de Atacama Commercial DLE Project permitting
Start: initiated environmental permitting process

Benefit:evaluates up to 6 trains of DLE

Investments would be phased in a prudent manner, contingent on approvals and investment decisions.

Kings Mountain Project permitting

Currently obtaining required permits and conducting comprehensive economic and environmental predevelopment evaluations prior to making a final investment decision. Recently received federal mining permits.

Risks & headwinds

Global supply chain disruptions related to the Middle East Full-year 2026

Estimated full year cost impact of $70 million to $90 million

Mitigation:Expected to be offset by reduced interest expense and stronger Specialties business performance.

Geopolitical tensions Near-term and H2 2026

Volatility in petrochemicals and oil and gas end markets; uncertainty in Specialties outlook for H2

Mitigation:Company maintains diverse portfolio and global operations to pivot to meet dynamic market needs; monitoring closely.

Timing of spodumene inventory consumption and higher costs due to supply chain disruptions Q2 FY26

Energy Storage EBITDA margin expected to decrease sequentially in Q2

Greenbushes JV partner concerns regarding safety, grade recoveries, and production stability Ongoing

JV partner went public with concerns, contrasting with Albemarle's view that operations are on plan.

Mitigation:Albemarle is working on a safety plan and states the mine is operating to its plan, including CGP3 ramp-up.

Bromine price easing in China H2 FY26

Contributes to caution for Specialties outlook in H2

Mitigation:Albemarle's diversified global supplier position and value chain approach to pricing.

What to watch in Q2 FY26

Specialties Segment Performance

H2 FY26
Current Q1 net sales up 12% YoY, adjusted EBITDA up 30% YoY
Target Continued strong performance, maintaining or exceeding raised full-year outlook

Why it matters

Management expressed caution for H2 due to geopolitical tensions and bromine price easing, making sustained performance critical for the raised full-year outlook.

Looking ahead and taking all these factors into consideration, we are increasing the range of our full year outlook considerations for the Specialties segment. ... While outlooks for end markets such as petrochemicals and oil and gas remain volatile due to geopolitical tensions, this increase in outlook reflects bromine price and volume opportunities that we see, coupled with our strong operational execution and the success of our cost and productivity improvements.

Find out whether ALB delivers this. Inve re-checks your case every morning.

Q&A highlights

Has higher lithium pricing changed buyer behavior? What are the cost benefits of DLE in Chile?

Management noted no significant change in buyer behavior yet, but conversations are evolving, with strong interest in spot bids and contracts, especially for Energy Storage. DLE in Chile is primarily about accessing more lithium under environmental conditions, not cost improvement.

“So it's more about being able to access more lithium in the Salar at the cost position we're at rather than trying to do -- it's not really a cost improvement program, it's about being able to access more lithium in the Salar under kind of the environmental conditions there.”

asked by David Begleiter · answered by Jerry Masters

2 min read 5 chapters

Detailed narrative

Q1 Performance Highlights

Albemarle reported Q1 FY26 net sales of $1.4 billion, a 33% year-over-year increase, and adjusted EBITDA of $664 million, more than double the prior year. This strong performance was driven by higher pricing and volumes in both Energy Storage and Specialties segments, alongside ongoing cost and productivity improvements. The company's adjusted EBITDA margin expanded by over 20 percentage points YoY, contributing to diluted earnings of $2.34 per share.

Strategic Portfolio and Market Outlook

The company's portfolio is well-positioned in resilient end markets, with over half of net sales in new energy markets like EVs and energy storage. Global lithium demand is tracking in line with forecasts, up 37% year-to-date, within the 2026 forecast range of 15% to 40%. Strong growth in the energy storage sector compensated for weaker EV sales in Q1, particularly in China and the US, while European and developing markets showed robust EV growth.

Operational Excellence and Cost Management

Albemarle is on track to achieve its full-year cost and productivity improvement target of $100 million to $150 million, having already realized $40 million in savings. These improvements are crucial for offsetting estimated full-year supply chain disruption costs of $70 million to $90 million. Efforts include debottlenecking projects such as increasing spodumene utilization at lithium conversion facilities in China and ramping new assets to their full production capability.

Balance Sheet Strengthening and Capital Allocation

The company repaid $1.3 billion of debt in Q1, reducing its weighted average interest rate to 3.1% and annual interest expense by approximately $60 million. This action strengthened the balance sheet, resulting in a net debt-to-EBITDA leverage ratio of 1x, and provides substantial financial flexibility with no major maturities until late 2028. Full-year capital expenditures are expected to be $550 million to $600 million.

Growth Projects and Future Capacity

Operations at Wodgina and Greenbushes joint ventures are performing as expected, with the CGP3 investment at Greenbushes operational and ramping as planned. Albemarle is pursuing brownfield expansion opportunities at existing assets like Greenbushes, Wodgina, and Salar de Atacama for the next phase of growth post-2027, requiring minimal additional CapEx for current ramp-ups. The company is also advancing direct lithium extraction (DLE) permitting at Salar de Atacama and federal mining permits for Kings Mountain.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.